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Abstract
Objective: o examine the relation between mouse allergen exposure and asthma in Puerto Rican children.
Methods: Mus m 1, Der p 1, Bla g 2, and Fel d 1 allergens were measured in dust samples from homes of Puerto Rican
children with (cases) and without (controls) asthma in Hartford, CT (n = 449) and San Juan (SJ), Puerto Rico (n = 678). Linear
or logistic regression was used for the multivariate analysis of mouse allergen (Mus m 1) and lung function (FEV1 and FEV1/
FVC) and allergy (total IgE and skin test reactivity (STR) to $1 allergen) measures.
Results:
associated with higher FEV1 in cases in Hartford (+70.6 ml, 95% confidence interval (CI) = 8.6–132.7 ml, P = 0.03) and SJ
(+45.1 ml, 95% CI = 20.5 to 90.6 ml, P = 0.05). In multivariate analyses of controls, mouse allergen was inversely associated
with STR to $1 allergen in non-sensitized children (odds ratio [OR] for each log-unit increment in Mus m 1= 0.7, 95%
CI = 0.5–0.9, P,0.01). In a multivariate analysis including all children at both study sites, each log-increment in mouse
allergen was positively associated with FEV1 (+28.3 ml, 95% CI = 1.4–55.2 ml, P = 0.04) and inversely associated with STR to
$1 allergen (OR for each log-unit increment in Mus m 1= 0.8, 95% CI = 0.6–0.9, P,0.01).
Conclusions: ouse allergen is associated with a higher FEV1 and lower odds of STR to$1 allergen in Puerto Rican children.
This may be explained by the allergen itself or correlated microbial exposures.
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Introduction
Mouse allergen (Mus m 1) exposure is common in the mainland
United States, where higher allergen levels are found in inner-city
or urban areas[[1,2,3,4]]. Published studies of mouse allergen and
asthma or asthma morbidity have yielded discrepant results, likely
due to differences in study design, analytical approach, allergen
levels, and characteristics of study participants.
In a cross-sectional study of 499 inner-city children with asthma
in the U.S. mainland, exposure to mouse allergen levels above the
median (1.6 mg/g) was associated with mouse allergy but not with
asthma morbidity[[5]]. Among 127 preschool children with
asthma in Baltimore, those highly exposed to mouse allergen
(defined as a level above the lowest quartile or $0.5 mg/g) and
allergic to mouse had greater asthma morbidity (parental report of
symptoms and exacerbations) than those exposed to ,0.5 mg/g or
those exposed to $0.5 mg/g but not allergic to mouse[[6]]. Of
note, asthma morbidity in children with high allergen exposure
but no mouse allergy was not compared to that of other children.
A cross-sectional study of children (n= 726) and adults
(n = 1,643) in the U.S. mainland found that exposure to
$1.6 mg/g of mouse allergen (a threshold used in a prior
study[[5]]) was associated with twofold increased odds of current
asthma in subjects with self-reported doctor-diagnosed allergies,
even after accounting for exposure to other allergens[[4]];
however, there was no significant association in subjects without
self-reported allergies (odds ratio [OR]= 0.7, 95% confidence
interval [CI] = 0.3–1.5) [[4]]. In a birth cohort study of 498
children with parental history of asthma or allergies, detectable
mouse allergen at age 2–3 months was not significantly associated
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Homes in SJ had lower mouse allergen levels than those in Hartford. In multivariate analyses, mouse allergen was
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with wheeze in the first year of life after adjustment for cockroach
allergen[[7]]. In a follow-up study of the same children up to age 7
years, detectable mouse allergen at age 2–3 months was
significantly associated with transient wheeze but not with
persistent or late-onset wheeze, asthma (OR=0.6, 95%
CI= 0.3–1.3), allergic rhinitis or eczema[[8]]. Although there
was a significant association between mouse allergen exposure and
skin test reactivity (STR) to $1 allergen (OR=2.0, 95% CI= 1.1–
3.7), only 248 (49.8%) of the 498 participants had allergy skin
testing at school age. More recently, a birth cohort study of 500
children in the U.S. mainland reported an inverse association
between exposure to mouse allergen at age 3 months (analyzed as
a continuous log-transformed variable) and single wheeze or
allergic sensitization at age 1 year[[9]].
Puerto Ricans, who are U.S. citizens, bear a disproportionate
burden of asthma in this country[[10,11,12,13]]. In spite of high
likelihood of mouse allergen exposure among Puerto Ricans in
urban areas, there has been no study of mouse allergen and
asthma in this ethnic group. In this report, we examine the relation
between mouse allergen and asthma, lung function and atopy in a
case-control study of Puerto Rican children living in two cities in
the U.S. Northeast (Hartford, Connecticut) and the island of
Puerto Rico (San Juan).
Materials and Methods
Subject Recruitment
A detailed description of the Methods is provided in Methods
S1.
From September of 2003 to July of 2008, informational flyers
were distributed to all parents of children in grades K-8 in 15
public elementary/middle schools in Hartford that enroll a
significant proportion (42% to 94%) of Puerto Rican children.
Of 640 children whose parents were interested in the study, 585
(91. 4%) were eligible for inclusion after completion of a screening
questionnaire; parents of 449 (76.7%) of these 585 children agreed
to participate. There were no significant differences in age, gender,
or area of residence between eligible children who did (n = 449)
and did not (n = 136) agree to participate. Of these 449 children,
427 (95.1%) had data on indoor allergens and were thus included
in this analysis.
From March of 2009 to June of 2010, children in San Juan (SJ)
were chosen from randomly selected households, using a scheme
similar to that of a prior study[[14]]. In brief, households in the
Standard Metropolitan Area of SJ were selected by a multistage
probability sample design[[14]]. Primary sampling units (PSUs)
were randomly selected neighborhood clusters based on the 2000
U.S. census, and secondary sampling units were randomly selected
households within each individual PSU. A household was eligible
if $1 resident was a child 6 to 14 years old. In households with
more than one eligible child, a maximum of five children were
randomly selected. Within each housing unit selected, children
were enumerated and one child per eligible household was
selected for screening. In households with multiple eligible
children, one child was randomly selected by using Kish tables.
On the basis of the sampling design, a total of 7,073 households
were selected for inclusion; 6,401 (90.5%) were contacted. Of these
6,401 households, 1,111 had $1 child within the age range of the
study who met other inclusion criteria (see below). In order to
reach our target sample size (,700 children), we attempted to
enroll a random sample (n = 783) of these 1,111 children. Parents
of 105 (13.4%) of these 783 eligible households refused to
participate or could not be reached. There were no significant
differences in age, gender, or area of residence between eligible
children who did (n = 678) and did not (n = 105) agree to
participate.
In both study sites, the main recruitment tool was a screening
questionnaire given to parents of children ages 6 to 14 years to
obtain information about the child’s respiratory health and Puerto
Rican ancestry. All participants (cases and controls) had to have
four Puerto Rican grandparents and be living in the same
household for $1 year. We selected as cases children with
physician-diagnosed asthma and wheeze in the prior year, and as
controls children with no physician-diagnosed asthma and no
wheeze in the prior year.
Study Procedures
A description of all study procedures is provided in Methods
S1. Participants at both sites completed a protocol that included
questionnaires, spirometry, allergy skin testing, and collection of
blood (for measurement of serum total IgE) and dust samples. Dust
samples were obtained from three areas in the home: the one in
which the child sleeps (usually his/her bedroom), the living room/
television room, and the kitchen. The dust was sifted through a 50-
mesh metal sieve, and the fine dust was reweighed, extracted, and
aliquoted for analysis of allergens from mouse (mouse urinary
protein [Mus m 1]), dust mite (Dermatophagoides pteronyssinus
[Der p 1]), cockroach (Blatella germanica [Bla g 2]), and cat
dander (Fel d 1) using two-site monoclonal antibody ELISA assays.
Ethics Statement
Written parental consent was obtained for participating
children, from whom written assent was also obtained. The study
was approved by the Institutional Review Boards (IRBs) of
Connecticut Children’s Medical Center (Hartford [Protocol
#135503]), the University of Puerto Rico (SJ [Protocol #
0160507]), Brigham and Women’s Hospital (Boston, MA [Proto-
col # 2007P-001174), and the University of Pittsburgh (Pitts-
burgh, PA [Protocol # PRO10030498]).
Statistical Analysis
Non-detectable allergen levels were assigned a constant (half the
lowest detectable value). Allergen levels were analyzed as
continuous (after log10-transformation). Our outcomes of interest
were FEV1 and FEV1/FVC, total serum IgE, and STR to $1
allergen. All analyses were first conducted separately in children
with (cases) and without (controls) asthma at each study site. Given
results of prior studies, we then conducted analyses stratified by
STR to mouse in the combined cohort (including children in
Hartford and SJ) because of small sample size at either study site.
Univariate analyses were conducted using Fisher exact tests for
categorical variables and two-tailed t tests for categorical and
continuous variables. Linear or logistic regression was used to
study the relation between mouse allergen and the outcomes of
interest while adjusting for potential confounders. All multivariate
models included mouse allergen, age, sex, household income (,
vs.$$15,000/year [the median household income for Puerto Rico
in 2008-2009]), parental (maternal or paternal) history of asthma,
and levels of other allergens (cockroach, cat and dust mite); all
analyses of FEV1 were additionally adjusted for height and height
squared. Multivariate analyses of the combined cohort were
additionally adjusted for study site. Results with P-values ,0.05
were considered significant and those with P values $0.05 but
,0.10 were considered as of borderline statistical significance. All
statistical analysis was performed using SAS statistical software,
version 9.2 (SAS Institute; Cary, NC).
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Results
Table 1 summarizes the main characteristics of study
participants. Compared to control subjects at each study site,
cases were more likely to have a parental history of asthma, a
lower FEV1/FVC, higher total IgE, and STR to $1 allergen. In
SJ, cases were more likely to have low FEV1 and to have STR to
dust mite or cockroach than controls; in Hartford, cases were more
likely to have STR to cat than controls. At each study site, there
was no significant difference in exposure to mouse or any of the
other allergens between cases and controls.
Children in SJ (cases or controls) were more likely to have STR
to the allergens tested than those in Hartford. Households of
children (cases or controls) in SJ had lower levels of mouse and cat
allergens but higher levels of dust mite allergen than those of
children in Hartford (Table 1 and Figure 1). In Hartford, mouse
allergen was weakly but significantly correlated with all other
allergens (cockroach, cat, and dust mite) in cases, as well as with
cockroach allergen in controls. In SJ, mouse allergen was
significantly correlated with dust mite allergen in cases; there
was no other significant correlation in cases or controls (Figure 2).
Table 1. Main characteristics of study participants.
San Juan, PR Hartford, CT
Cases Controls Cases Controls
N 351 327 267 182
Mean age (yrs) 10.0 (2.6)* 10.5 (2.7) 9.9 (2.8) 9.7 (2.8)
Male gender 57.3%* 48.8% 49.8% 47.3%
Parental asthma:
N Mother 49.1%* 20.9% 47.0%* 28.1%
N Father 34.05%& 15.5% 35.8* 17.7%
N Either parent 68.1%* 33.2% 66.3%* 44.7%
Parental education:
N High school or less 45.3% 48.2% 28.5% 26.1%
N At least some college 48.1% 46.6% 64.0% 63.0%
N Missing 6.6% 5.2% 7.5% 10.9%
Household income:
N ,$15,000/year 66.1% 63.2% 56.2% 59.8%
N $$15,000/year 33.9% 35.3% 33.3% 29.9%
N Missing 0% 1.5% 10.5% 10.3%
Home allergen levela
N Mus m 1 (ng/g) 6.5 (2.0–31.0) 7.0 (2.0–28.0) 80.6 (15.8–231) 76.8 (27.0–303)
N B.germanica (U/g) 1.30 (.73–4.39) 1.20 (.73–2.75) 1.12 (.30–4.04) 1.58 (.30–4.75)
N Fel d 1 (mg/g) .02 (.006–.06){ .02 (.008–.15) .36 (.13–1.41) .25 (.12–1.23)
N Der p (mg/g) 4.51 (2.42–9.57) 4.45 (1.94–9.43) .15 (.15–.50) .15 (.15–.56)
Spirometry (N) 287 273 266 181
FEV1 (liters) 1.90 (0.70)* 2.07 (0.77) 1.92 (0.71) 2.00 (0.71)
FEV1/FVC 80.8 (9.1)* 83.0 (9.6) 82.1 (8.7)* 84.7 (9.1)
Allergy markers (N) 305 285 257 168
Total IgE (IU/mL)a 346 (116–881)* 155 (44–586) 118 (40–348)* 67 (25–303)
Positive STR (N) 285 260 267 182
N Mouse 26.2% 21.2% 4.7% 1.4%
N Cockroach 40.1%* 27.5% 21.4%{ 14.3%
N Cat 37.0% 34.0% 24.2%* 12.1%
N Dust mite 55.4%* 41.8% 33.9% 27.9%
N Mold 12.2% 14.0% 4.7% 1.4%
N $ 1 allergen 84.2%* 75.0% 47.2%* 35.2%
Mean (SD) for continuous variables, except
apresented as median (IQR), analyzed as log10.
*P-value,0.05 and {P,0.10 for cases vs controls within each group.
STR = skin test reactivity.FEV1 shown as absolute value because of lack of predicted values in Puerto Ricans.
doi:10.1371/journal.pone.0040383.t001
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Figure 1. Distribution of allergen levels (log-transformed), by study site.
doi:10.1371/journal.pone.0040383.g001
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Next, we assessed whether allergen exposure influences lung
function and atopy in children with asthma (cases). There were
slight differences in mouse or cockroach allergen level but
otherwise no significant differences between cases with and
without spirometry or allergy skin testing (AST) in SJ (Table
S1). All cases in Hartford had AST, and only one did not undergo
spirometry.
Table 2 shows the results of the unadjusted analysis of quintiles
of mouse allergen, FEV1 and allergy markers in cases. In SJ,
mouse allergen level was significantly and linearly associated with
higher FEV1 and lower prevalence of STR to cockroach. In
Hartford, mouse allergen level was linearly associated with higher
FEV1 (P= 0.10). There was no significant association between
mouse allergen and FEV1/FVC at either study site. Table 3
shows the results of the multivariate analyses of mouse allergen
and the outcomes of interest in cases. After adjusting for exposure
to other allergens and other covariates, mouse allergen was
associated with higher FEV1 in SJ and in Hartford, and with lower
total IgE in SJ (P#0.05 in all instances). In this multivariate
analysis, dust mite allergen was significantly associated with lower
FEV1 and STR to $1 allergen in Hartford.
Given results from previous studies and consistent results across
sites in the current study, we repeated the analysis after
stratification by STR to mouse in the combined cohort to
maximize our statistical power (Table 4). Among cases sensitized
to mouse, there was no significant association between mouse
allergen and any outcome (P$0.75 in all instances). Among cases
not allergic to mouse, mouse allergen was associated with higher
FEV1 (P= 0.07).
Use of inhaled steroids and use of leukotriene receptor
antagonists were reported by parents of 34.5% (31.9% in San
Juan, 37.5% in Hartford, P= 0.17) and 21.2% (23.9% in San
Juan, 18.0% in Hartford, P= 0.09) of cases. In the combined
cohort, use of inhaled steroids was associated with lower FEV1
(P= 0.09) and use of leukotriene receptor antagonists (LTRA) was
associated with higher total IgE (P= 0.01). We obtained similar
Figure 2. Allergen level correlations in cases and controls, by study site. Correlations with P,0.05 have a regression line and confidence
intervals.
doi:10.1371/journal.pone.0040383.g002
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results after additional adjustment of our multivariate analysis for
use of controller medications (data not shown).
We then examined the relation between mouse allergen and the
outcomes of interest in children without asthma (controls). In SJ,
controls without spirometry had lower total IgE than those with
spirometry (Table S1). All controls in Hartford had AST, and
only one did not have spirometry. Table S2 (Online Supple-
ment) shows the results of the analysis of quintiles of mouse
allergen and the outcomes of interest in controls. In SJ, there was
no significant association between mouse allergen and any of the
outcomes. In Hartford, mouse allergen was significantly associated
with lower total IgE and lower odds of STR to dust mite or to $1
allergen. Table S3 shows the results of the multivariate analyses
of mouse allergen and the outcomes of interest in controls. In this
analysis, mouse allergen was associated with higher FEV1 in SJ,
and with lower total IgE in Hartford (P,0.10 in both instances). In
an analysis stratified by STR to mouse in all control subjects,
mouse allergen was associated with lower total IgE (P = 0.10) and
lower odds of STR to $1 allergen (P,0.01) only among children
not allergic to mouse (Table S4a, Online Supplement).
We then conducted an analysis stratified by STR to mouse in all
children (cases and controls) at each study site and for the
combined cohort (Table S4b, Online Supplement). In the
multivariate analysis of the combined cohort (adjusting for case-
Table 2. Mouse allergen level, selected covariates, and measures of lung function and atopy in children with asthma.
Quintile of mouse allergen level Q1 Q2 Q3 Q4 Q5 P for trend
Range (ng/g) (.05–2.86) (3.0–10.0) (10.2–42.0) (42.02–183.6) (184–31,227)
SAN JUAN
N (%) 83 (28.4) 91 (31.2) 50 (17.1) 27 (9.3) 41 (14.0)
Mean age (yrs) 10.1 (2.5) 9.7 (2.6) 10.1 (2.7) 9.8 (2.8) 10.8 (2.6) 0.20
Male gender 60% 55% 61% 64% 56% 0.99
Parental asthma 67% 74% 63% 78% 68% 0.90
Parental education beyond high school 52% 48% 43% 61% 59% 0.37
Household income $$15,000/year 31% 36% 30% 15% 29% 0.28
FEV1 (liters)* 1.86 (0.65) 1.82 (0.69) 1.85 (0.69) 1.92 (0.79) 2.18 (0.72) 0.02
FEV1/FVC (%) 81.8 (7.5) 80.5 (8.2) 79.2 (0.12) 80.1 (11.9) 81.9 (6.8) 0.80
Total IgE (IU/ml)a 418 (138–778) 360 (130–890) 195 (59–668) 397 (86–830) 218 (48–867) 0.06
STR(+) to:
N Mouse 31% 28% 23% 21% 21% 0.18
N Cockroach 51% 40% 34% 22% 29% 0.007
N Cat 42% 40% 29% 28% 32% 0.14
N Dust mite 61% 56% 47% 48% 47% 0.09
N Mold 12% 15% 17% 9% 9% 0.70
N $ 1 allergen 87% 84% 83% 72% 82% 0.23
HARTFORD
N (%) 13 (5.0) 29 (11.1) 56 (21.4) 91 (34.9) 72 (27.6)
Mean age (yrs) 9.5 (2.7) 8.8 (2.3) 10.2 (2.8) 10.0 (2.7) 10.0 (3.1) 0.19
Male gender 62% 38% 61% 46% 47% 0.52
Parental asthma 62% 71% 57% 68% 72% 0.31
Parental education beyond high school 62% 59% 61% 70% 61% 0.09
Household income $$15,000/year 46% 52% 45% 29% 24% 0.0003
FEV1 (liters)* 1.76 (0.50) 1.69 (0.57) 1.94 (0.66) 1.96 (0.73) 1.99 (0.78) 0.10
FEV1/FVC (%) 82.4 (10.6) 80.2 (7.6) 83.2 (7.0) 82.0 (9.4) 82.4 (9.0) 0.99
Total IgE (IU/ml)a 387 (55–345) 109 (24–239) 92 (31–220) 115 (56–345) 146 (51–411) 0.43
STR(+) to:
N Mouse 0% 8% 2% 8% 2% 0.79
N Cockroach 20% 12% 19% 23% 24% 0.26
N Cat 20% 24% 19% 28% 24% 0.61
N Dust mite 40% 28% 29% 35% 36% 0.57
N Mold 10% 4% 2% 5% 5% 0.98
N $ 1 allergen 62% 52% 45% 45% 47% 0.46
Quintiles (and ranges) calculated using the combined cohort (San Juan and Hartford). Values shown are mean (SD) for continuous variables, except
apresented as median (IQR), analyzed as log10.
STR = skin test reactivity.
*FEV1 presented as absolute value due to lack of predicted values for Puerto Rican children.
doi:10.1371/journal.pone.0040383.t002
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control status, study site, allergen levels and other covariates)
mouse allergen was significantly associated with higher FEV1 and
lower odds of STR to $1 allergen (P,0.01 in both instances) in
children not sensitized to mouse.
Discussion
To our knowledge, this is the first study of mouse allergen
exposure and lung function. This is also the first study of mouse
Table 3. Multivariate analysis of mouse allergen, FEV1, and allergy markers in children with asthma.
Predictors included in the
model Pre-bronchodilator FEV1 (mL)1 Total serum IgE1 STR to at least one allergen2
SAN JUAN
Unadjusted (N) 266 283 264
Mus m 1 (ng/g) +93.9 [13.1;174.8] (0.02) 217.7% [231.3;21.4] (0.03) 0.84 [0.62;1.13] (0.25)
Multivariate model (N) 266 283 264
Mus m 1 (ng/g) +45.1 [20.5;90.6] (0.05) 217.5% [231.2;21.1] (0.04) 0.82 [0.60;1.12] (0.20)
Fel d 1 (mg/g) 28.3 [260;43.] (0.75) 213.4% [229;6] (0.16) 0.9 [0.6;1.2] (0.43)
Bla g (U/g) 213.0 [281;55] (0.71) 219.7% [239;5] (0.11) 0.7 [0.4;1.1] (0.12)
Der p (mg/g) +11.7 [280;104] (0.80) +37.8% [24;99] (0.09) 1.03 [0.5;2.0] (0.92)
HARTFORD
Unadjusted (N) 260 252 261
Mus m 1 (ng/g) +107.8 [5.7;210.0] (0.04) +20.8% [23.7;51.5] (0.10) 0.95 [0.71;1.26] (0.71)
Multivariate model (N) 203 195 204
Mus m 1 (ng/g) +70.6 [8.6;132.7] (0.03) +10.9 [217.8;49.6] (0.50) 0.82 [0.55;1.22] (0.32)
Fel d 1 (mg/g) +54.3 [27;116] (0.08) 215.7% [238;14] (0.26) 0.9 [0.6;1.3] (0.57)
Bla g (U/g) 220.1 [286;45] (0.55) +9.8% [221;52] (0.57) 1.0 [0.6;1.5] (0.85)
Der p (mg/g) 2128.9 [2212; 246] (0.002) +45.3% [22;115] (0.06) 1.9 [1.1;3.2] (0.03)
Values shown are 1means or 2odds ratios and 95% confidence intervals, with P-values in parentheses. All allergens analyzed as log10. IgE analyzed as log10 and
presented as percent increase/decrease. All models adjusted for age, sex, household income, and dust house levels of allergens. FEV1 adjusted additionally for height
and height squared.
doi:10.1371/journal.pone.0040383.t003
Table 4. Multivariate analysis of mouse allergen level and selected outcomes in cases, by skin test reactivity to mouse.
Predictors included in the
model Pre-bronchodilator FEV1 (mL)1 Total serum IgE1 STR to at least one allergen2,3
STR(+) to mouse
Unadjusted (N) 69 70 n/a
Mus m 1 (ng/g) 241.3 [2197.8;115.3] (0.61) +1.6% [227.4;42.3] (0.92)
Multivariate model (N) 66 67 n/a
Mus m 1 (ng/g) 213.7 [299.9;72.5] (0.76) 25.8% [235.0;36.6] (0.75)
Fel d 1 (mg/g) +4.2 [288;97] (0.93) 210.4% [239;31] (0.57)
Bla g (U/g) +3.2 [294;158] (0.62) 231.4% [260;18] (0.17)
Der p (mg/g) 210.2 [2181;161] (0.91) +22.1% [239;146] (0.58)
STR(–) to mouse
Unadjusted (N) 358 369 372
Mus m 1 (ng/g) +94.8 [27.1;162.5] (0.006) 214.5% [227.5;1.0] (0.06) 0.77 [0.62;0.95] (0.017)
Multivariate model (N) 317 328 331
Mus m 1 (ng/g) +34.4 [22.5;71.3] (0.07) 26.6% [222.5;12.7] (0.48) 0.85 [0.65;1.11] (0.22)
Fel d 1 (mg/g) +26.0 [216;68] (0.22) 214.1% [231;6] (0.16) 0.8 [0.6;1.1] (0.11)
Bla g (U/g) +12.8 [236;62] (0.61) 213.8% [233;11] (0.25) 0.8 [0.6;1.1] (0.21)
Der p (mg/g) 257.5 [2120;5] (0.07) +41.1% [2;95] (0.04) 1.4 [0.9;2.2] (0.17)
Values shown are 1means or 2odds ratios and 95% confidence intervals, with P-values in parentheses. All allergens analyzed as log10. IgE analyzed as log10 and
presented as percent increase/decrease. 3All children allergic to mouse were also sensitized to $1 additional allergen. All models adjusted for age, sex, household
income, other allergens, and study site. FEV1 adjusted additionally for height and height squared.
doi:10.1371/journal.pone.0040383.t004
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allergen exposure and asthma or asthma morbidity in Puerto
Ricans.
Among cases, we found that mouse allergen was associated with
higher FEV1 in Hartford and SJ, and that this association
remained significant only in children not sensitized to mouse.
Among controls, mouse allergen was associated with lower odds of
STR to $1 allergen in children not sensitized to mouse. In an
analysis including all participants (Table S4b), mouse allergen was
significantly associated with higher FEV1 and lower odds of STR
to $1 allergen in children not sensitized to mouse.
Our overall findings are interesting and partly consistent with a
recent report of an inverse association between exposure to mouse
allergen at age 3 months and single wheeze or allergic sensitization
at age 1 year[[9]]. Although additional replication is needed, our
results suggest that mouse allergen or a factor correlated with this
exposure is associated with a higher FEV1 and reduced intensity of
allergic responses in Puerto Rican children. Previous studies have
shown that Hispanic (including Puerto Rican) children with/at risk
for asthma are less likely to have cats or dogs[[15,16] [17]], and
thus mouse allergen may be a marker of increased exposure to
microbial components in mammalian feces (endotoxin or muramic
acid[[18,19]]) in Puerto Rican children.
In our study, children living in Hartford were exposed to higher
levels of mouse allergen but lower levels of dust mite allergen than
those living in SJ. Consistent with prior findings in inner-city
children in the U.S. Northeast[[5,6]], mouse allergen levels in
Hartford were significantly correlated with cockroach allergen in
cases and controls (r = 0.20–0.30, P,0.05). In contrast, there was no
significant correlation between mouse allergen and cockroach
allergen in cases or controls living in a tropical environment (SJ).
Unlike participants in prior studies of inner-city children in the U.S.
Northeast, most participants in Hartford were not allergic tomouse,
which may be explained by attenuated humoral (IgE) responses in
children exposed to high levels of mouse allergen[[20]]. Additional
differences between our study and previous reports include sample
size[[1,2,3,5,6,7,8]], ethnicity of the partici-
pants[[1,2,3,4,5,6,7,8,9]], level of exposure to mouse aller-
gen[[1,2,3,4,5,6,7,8,9]], and analytical approach[[1,2,3,4,5,6,7,8]]
(all studies showing detrimental or no effects of mouse allergen on
asthma morbidity mainly assessed mouse allergen as a categorical
variable).
The only previous study of allergen exposure and asthma in
Puerto Rico included ,82–89 children with asthma (ages 1 to 17
years) living in the city of Bayamo´n[[17]]. Compared to our
findings for cases in SJ (Table 1), that study reported similar
average levels of Der p 1 or Der f 1 (4.3 mg/g) but lower average
levels of Bla g 2 (0.75 U/g) in house dust (only collected from the
child’s mattress and bedside floor); there was no assessment of Mus
m 1. In bivariate analyses, none of the allergens included in the
current study was significantly associated with asthma symptoms.
Although those results could be explained by low statistical power,
they are consistent with our negative findings for allergens other
than mouse in SJ. As speculated in that prior study, dust mite or
cockroach allergen level in house dust may not adequately reflect
airborne allergen exposure in Puerto Rico (where homes may be
more ventilated homes than in the U.S. Northeast). Alternatively,
there may be differences in other (unmeasured) environmental
exposures across study sites such as indoor endotoxin or fungal
allergens, or outdoor air pollution.
Our findings for dust mite allergen and FEV1 in Hartford are
consistentwith thoseofGent et al.,who founda significant association
between Der p 1 levels $2 mg/g and increased asthma severity
(assessed by questionnaire) over 1 year of follow-up in 300 children
(ages4 to12years)withasthma (18.3%ofwhomwereHispanic) in the
U.S. Northeast (including Connecticut) [[21]]. Consistent with our
results in Hartford but in contrast to a prior report in inner-city U.S.
children[[22]], Gent et al. found no significant association between
cockroach allergen and asthma severity[[21]].
Adjustment of the multivariate analysis of Mus m 1 and the
outcomes of interest for Der p 1 and other allergens did not
change the direction of the observed associations but sometimes
led to marked changes in the magnitude of such associations (e.g.,
see the unadjusted and adjusted results for Mus m 1 and FEV1 in
Table 3). This stresses the importance of accounting for other
allergens in future studies of Mus m 1.
We recognize several limitations to our findings. Firstly,
selection bias is possible in any observational study, particularly
one of ethnic minorities. However, selection bias is an unlikely
explanation for our results in general and in SJ in particular.
Children in SJ were randomly sampled, and most (,87%) eligible
children participated in the study. Among participating children in
Hartford or SJ, there were no marked differences in allergen levels
or other covariates between children who did and did not
complete key study procedures (spirometry or AST). Secondly, we
cannot assess the effects of allergen exposure in early life on
asthma or allergy in a cross-sectional study of children of school
age. However, a cross-sectional study of allergen exposure and
lung function is valid and can yield useful information. Thirdly, we
are not able to adequately examine mouse allergen and lung
function or atopy in children sensitized to mouse because of small
sample size for that subgroup. Lastly, conducting subgroup
analyses increases the risk of false positive findings. However,
the observed associations forFEV1 and STR to $1 allergen were
consistent in direction (positive for FEV1 and negative for STR to
$1 allergen) across study sites and asthma status, and they were
significant among all children not sensitized to mouse after
adjustment for potential confounders. Differences in the magni-
tude or degree of significance across study sites or among
subgroups may at least partly be due to variations in the
distribution of mouse allergen and/or sample size.
In summary, mouse allergen exposure was associated with
higher FEV1 and lower odds of STR to $1 allergen in Puerto
Rican children. Our findings merit further assessment of factors
that could mediate this association (e.g., microbial exposures
associated with the presence of mice).
Supporting Information
Methods S1 S1. Subject recruitment. S2. Study Procedures.
(DOC)
Table S1 Mean (SD) for continuous variables, except apresented
as median (IQR), analyzed as log10. *P,0.05 for comparison
within each outcome. STR= skin test reactivity.
(DOC)
Table S2 Quintiles (and ranges) calculated using the combined
cohort (San Juan and Hartford). Values shown are mean (SD) for
continuous variables, except apresented as median (IQR), analyzed
as log10. STR= skin test reactivity. *FEV1 presented as absolute
value due to lack of predicted values for Puerto Rican children.
(DOC)
Table S3 Values shown are 1means or 2odds ratios and 95%
confidence intervals, with P-values in parentheses. All allergens
analyzed as log10. IgE analyzed as log10 and presented as percent
increase/decrease. All models adjusted for age, sex, household
income, and dust house levels of allergens. FEV1 adjusted
additionally for height and height squared.
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Table S4 Table S4a: Values shown are 1means or 2odds ratios
and 95% confidence intervals, with P-values in parentheses. 3All
children with STR to mouse also had STR to $ additional
allergen. All allergens analyzed as log10. IgE analyzed as log10
and presented as percent increase/decrease. All models adjusted
for age, sex, household income, dust house levels of allergens, and
study site. FEV1 adjusted additionally for height and height
squared. Table S4b, part A: Values shown are 1means or 2odds
ratios and 95% confidence intervals, with P-values in parentheses.
3All children with STR to mouse also had STR to $1 additional
allergen. All allergens analyzed as log10. IgE analyzed as log10
and presented as percent increase/decrease. All models adjusted
for age, sex, household income, dust house levels of allergens, and
disease status (case or control). FEV1 adjusted additionally for
height and height squared. Unable to conduct multivariate
analyses in Hartford. Table S4b, part B: Values shown are
1means or 2odds ratios and 95% confidence intervals, with P-
values in parentheses. All allergens analyzed as log10. IgE
analyzed as log10 and presented as percent increase/decrease.
All models adjusted for age, sex, household income, dust house
levels of allergens, and disease status (case or control). FEV1
adjusted additionally for height and height squared. Table S4b,
part C: Values shown are 1means or 2odds ratios and 95%
confidence intervals, with P-values in parentheses. 3All children
with STR to mouse also had STR to $1 additional allergen. All
allergens analyzed as log10. IgE analyzed as log10 and presented
as percent increase/decrease. All models adjusted for age, sex,
household income, dust house levels of allergens, study site, and
disease status (case or control). FEV1 adjusted additionally for
height and height squared.
(DOC)
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